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Abstract
The T lymphocyte-mediated immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with
tuberculous pleurisy is unknown. The aim of this study was to investigate the immune response in the parietal pleura of
tuberculous pleurisy compared with nonspecific pleuritis. We have measured the numbers of inflammatory cells particularly
T-cell subsets (Th1/Th2/Th17/Treg cells) in biopsies of parietal pleura obtained from 14 subjects with proven tuberculous
pleurisy compared with a control group of 12 subjects with nonspecific pleuritis. The number of CD3+, CD4+ and CCR4+
cells and the expression of RORC2 mRNA were significantly increased in the tuberculous pleurisy patients compared with
the nonspecific pleuritis subjects. The number of toluidine blue+ cells, tryptase+ cells and GATA-3+ cells was significantly
decreased in the parietal pleura of patients with tuberculous pleurisy compared with the control group of nonspecific
pleuritis subjects. Logistic regression with receiver operator characteristic (ROC) analysis for the three single markers was
performed and showed a better performance for GATA-3 with a sensitivity of 75%, a specificity of 100% and an AUC of 0.88.
There was no significant difference between the two groups of subjects in the number of CD8, CD68, neutrophil elastase,
interferon (IFN)-c, STAT4, T-bet, CCR5, CXCR3, CRTH2, STAT6 and FOXP3 positive cells. Elevated CD3, CD4, CCR4 and Th17
cells and decreased mast cells and GATA-3+ cells in the parietal pleura distinguish patients with untreated tuberculous
pleurisy from those with nonspecific pleuritis.
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Introduction
Tuberculosis is the second most important cause of death from
infectious diseases in the world. From 1990–2003, the incidence of
tuberculosis increased globally and currently more than one third of
the world’s population is infected with Mycobacterium tuberculosis [1].
Pleural Tuberculosis (PLTB) results from M.tuberculosis infection
of the pleura and can be associated with pulmonary tuberculosis
[2]. PLTB occurs in 4% of newly diagnosed cases of tuberculosis
and its frequency differs among countries [2,3]. The human
immunodeficiency virus (HIV) pandemic has been associated with
a doubling of the incidence of extrapulmonary tuberculosis, which
has resulted in increased recognition of PLTB even in developed
countries [4].
PLTB diagnosis depends on demonstration of M.tuberculosis in
sputum, pleural fluid or pleural biopsy specimens [2,4]. A
thoracoscopic biopsy of parietal pleura is the most sensitive
diagnostic test. Histological examination of pleural biopsy may
demonstrate granulomatous inflammation, caseous necrosis and/or
acid-fast bacilli [4]. Detection of M.tuberculosis DNA by polymerase
chain reaction (PCR) establishes the PLTB diagnosis. In contrast,
non specific pleuritis (NSP) is characterized by chronic inflamma-
tion and deposits of fibrin in the subpleural compartment [5].
The pathogenetic hypothesis of PLTB suggests that activated
CD3+ and CD4+ T-helper type (Th) 1 cells, through the release of
interferon gamma (IFN-c) and other Th1 cytokines, activate
macrophages to kill M.tuberculosis, whereas Th2 cytokines may
antagonize this effect [4]. The tuberculous pleural fluid is rich in
lymphocytes, particularly CD4+ T cells [6]. In addition many
studies support the presence of a Th1 polarization in pleural fluid
in PLTB [7–9] and the IFN-c level measurement has been
proposed as a method for PLTB diagnosis [4]. Activation of T
regulatory cells (Tregs; identified by the expression of the
transcription factor FOXP3) may avoid an excessive inflammatory
response and/or may compromise the elimination of M.tuberculosis.
Recent studies suggest an increased presence of Tregs in PLTB
[10,11]. Other studies, however, demonstrated that most clones
show a Th0 cytokine profile (production of both IFN-c and
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and clinical healing, most clones show a Th1 profile [12]. Finally,
some reports suggest the potential for a Th2 response [13,14].
M.tuberculosis infection can also induce IL-17 producing T-cell
subsets (Th17). The orphan nuclear receptor retinoic orphan
receptor (ROR)ct and its human homologue RORC2 are selective
markers for Th17 cells [15]. IL-17 is a potent inflammatory
cytokine capable of inducing chemokine expression and cell
recruitment into tissue. Both the IL-17 and the Th17 response to
M.tuberculosis are largely dependent upon IL-23 [16]. Th1 and
Th17 responses cross-regulate each other during infection and this
may be important for the immunopathology of tuberculosis [16].
There are no studies investigating T-cell subpopulations in
pleural biopsies obtained from PLTB patients and control groups.
The aim of the present study was to investigate the inflammatory
cellinfiltrate (CD3,CD4and CD8T cells,macrophages, neutrophil
and eosinophil granulocytes and mast cells) and a panel of Th1
(IFN-c, STAT4, T-bet, CCR5 and CXCR3+ cells), Th2 (CCR4,
CRTH2, GATA-3 and STAT6+ cells), Tregs (FOXP3+ cells) and
Th17 (RORC2 mRNA) markers in parietal pleural biopsies from
PLTB patients compared with a NSP control group.
Results
Histochemistry count for mast cells and eosinophil
granulocytes
The number of toluidine blue+ cells was significantly decreased
in PLTB patients compared with the NSP subjects (1.2660.91 vs
51.96629.14, p,0.009, Table 1 and Figure 1), whereas the
number of eosinophil granulocytes was not significantly different
between the two groups (100.0627.7 vs 65.2619.3 for PLTB and
NSP respectively, Table 1 and Figure 2).
Immunohistochemical count for inflammatory cells
The number of CD3+ and CD4+ cells was significantly
increased in PLTB patients compared with NSP subjects
(1549.06261.9 vs 328.8652.0 for CD3+ cells, p,0.001 and
1329.06213.8 vs 768.96144.5 for CD4+ cells, p=0.04) (Table 1
and Figures 3 and 4). In contrast, the number of tryptase+ cells
was significantly decreased in PLTB (0.860.5 vs 29.3611.7,
p=0.008) (Figure 1 and Table 1). No significant differences were
found in the number of CD8, CD68 and neutrophil elastase
immunoreactive cells (Table 1 and Figures 5, 6 and 7).
Immunohistochemical count for Th1, Th2 and Treg
markers
The GATA-3+ cell number was significantly decreased in
PLTB patients compared with NSP subjects (107.3678.0 vs
560.86152.4, p,0.001) (Table 1 and Figure 8). In addition, the
CCR4+ cell number was significantly increased in PLTB patients
(5.4162.27 vs 0.4560.45, p=0.03) (Table 1 and Figure 9). There
were no statistically significant differences in the number of IFN-c,
STAT6, CRTH2, CXCR3, CCR5, STAT4, T-bet, and FOXP3
immunoreactive cells between the two groups (Table 1 and
Figures 10, 11, 12, 13, 14, 15, 16, and 17).
Table 1. Quantification of inflammatory cells in the pleural biopsies.
PLTB NSP
Inflammatory cells CD3 1549.06261.9*** 328.8652.0
CD4 1329.06213.8* 768.96144.5
CD8 232.0656.0 165.8633.7
CD8 / CD4 0.4260.2 1.0560.33
CD68 398.1659.2 595.96225.0
Neutrophil elastase 21.2616.3 75.7649.7
Eosinophil granulocytes (hematoxylin and eosin staining) 100.0627.7 65.2619.3
Mast cells (toluidine blue staining) 1.2660.91** 51.96629.14
Mast cells (tryptase+) 0.860.5** 29.3611.7
Th1 markers IFN-c 281.5689.8 97.6637.4
CXCR3 2842.06484.1 2218.06422.5
CCR5 1607.06314.7 2092.06427.4
STAT4 329.0675.7 359.96127.0
T-bet 33.2617.9 10.865.7
T-bet / GATA-3 0.09960.08 0.01560.009
Th2 markers CCR4 5.4162.27* 0.4560.45
CRTH2 2305.06689.6 1900.06364.9
GATA-3 107.3678.0*** 560.86152.4
STAT6 13.9613.9 1.461.4
Tregs marker FOXP3 68.7638.2 5.961.8
Data are presented as means (6SE).
*p,0.05, significantly different from NSP group,
**p,0.01, significantly different from NSP group,
***p,0.001, significantly different from NSP group.
doi:10.1371/journal.pone.0022637.t001
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staining immunohistochemistry
We were unable to detect co-localization of both tryptase and
GATA-3 and Tbet and GATA-3 in the same cells in the parietal
pleura in PLTB or NSP subjects (Figures 8 and 18). Around 10%
of cells in the parietal pleura were both CD4 and CD8 positive
without any significant differences between PLTB vs NSP subjects.
The ratio of CD4/CD8 and Tbet/GATA-3 cells was not
significantly different in the parietal pleura in PLTB compared
with control NSP subjects (Table 1).
Quantification of RORC2 and IFN-c mRNA levels
RORC2 and IFN-c mRNA levels were significantly increased
in PLTB patients compared with NSP subjects (19.860.4 vs
18.060.3, p=0.007; 16.860.2 vs 14.960.5, p,0.01 respectively).
Overall accuracy of inflammatory cells and markers in the
differential diagnosis
To analyze the diagnostic accuracy of clinical and laboratory
parameters to predict PLTB, ROC analysis was performed for
toluidine blue staining for mast cells detection, tryptase+ cells and
Figure 1. Photomicrographs showing the parietal pleura stained for mast cells using immunostaining with an anti-tryptase
antibody (A and B) or toluidine blue histochemical staining (C and D). Tryptase+ cells are stained in red and toluidine blue+ cells are stained
in blue. Results are representative of those from 14 patients with PLTB (A and C) and 12 patients with NSP (B and D). Original magnification: 4006.
The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g001
Figure 2. Photomicrographs showing the parietal pleura stained for eosinophils using hematoxylin and eosin (H/E) histochemical
staining (A and B). Eosinophil granulocytes+ cells are stained in pink. Results are representative of those from 14 patients with PLTB (A) and 12
patients with NSP (B). Original magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g002
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22637Figure 3. Photomicrographs showing the parietal pleura (A and B) and control tonsil (C and D) immunostained for identification of
CD3+ cells (A–C). Photomicrographs D shows negative control slide of tonsils stained with normal nonspecific immunoglobulins of the same animal
species of the primary antibody used at the same protein concentration as the primary antibody. CD3+ cells are stained in brown. Results are
representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g003
Figure 4. Photomicrographs showing the parietal pleura (A and B) and control tonsil (C and D) immunostained for identification of
CD4+ cells (A–C). Photomicrographs D shows negative control slide of tonsils stained with normal nonspecific immunoglobulins of the same animal
species of the primary antibody used at the same protein concentration as the primary antibody. CD4+ cells are stained in brown. Results are
representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g004
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22637Figure 5. Photomicrographs showing the parietal pleura (A, B) and control tonsil (C and D) immunostained for identification of
CD8+ cells (A–C). Photomicrograph D shows negative control slide of tonsils stained with normal nonspecific immunoglobulins of the same animal
species of the primary antibody used at the same protein concentration as the primary antibody. CD8+ cells are stained in brown. Results are
representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g005
Figure 6. Photomicrographs showing the parietal pleura (A, B) and control tonsil (C and D) immunostained for identification of
CD68+ cells (A–C). Photomicrograph D shows negative control slide of tonsils stained with normal nonspecific immunoglobulins of the same
animal species of the primary antibody used at the same protein concentration as the primary antibody. CD68+ cells are stained in brown. Results are
representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g006
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22637Figure 7. Photomicrographs showing the parietal pleura (A, B) and control tonsil (C and D) immunostained for identification of
neutrophil elastase+ cells (A–C). Photomicrograph D shows negative control slide of tonsils stained with normal nonspecific immunoglobulins of
the same animal species of the primary antibody used at the same protein concentration as the primary antibody. Neutrophil elastase+ cells are
stained in red. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original magnification: 4006. The scale
bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g007
Figure 8. Photomicrographs showing the parietal pleura (A and B) immunostained for GATA-3+ cells or the parietal pleural (C and
D) double immunostained for GATA-3+ cells and tryptase+ cells. GATA-3 is stained in red in A and B and brown in C and D. Tryptase is
stained in red. Results are representative of those from 14 patients with PLTB (A and C) and 12 patients with NSP and (B and D). Original
magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g008
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22637Figure 9. Photomicrographs showing the parietal pleura (A, B) and control tonsil (C and D) immunostained for identification of
CCR4+ cells (A–C). Chemokine receptor CCR4+ cells are stained brown. Photomicrograph D shows negative control slide of tonsil immunostained
using normal nonspecific immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original
magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g009
Figure 10. Photomicrographs showing the parietal pleura (A, B) and positive control oral mucosa (C and D) immunostained for
identification of IFN-c+ cells (A–C). IFN-c+ cells are stained brown. Photomicrograph D shows negative control slide of oral mucosa surface
epithelium immunostained using normal nonspecific immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12
patients with NSP (B). Original magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g010
Local Immune Response in Tuberculous Pleurisy
PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22637Figure 11. Photomicrographs showing the parietal pleura (A, B) and positive control tonsil (C and D) immunostained for
identification of STAT6+ cells (A–C). STAT6+ cells are stained brown. Photomicrograph D shows negative control slide of tonsil immunostained
using normal nonspecific immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original
magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g011
Figure 12. Photomicrographs showing the parietal pleura (A, B) and positive control nasal polyp (C) immunostained for CRTH2
(A–C). CRTH2+ cells are stained in red. Photomicrograph D shows negative control slide of nasal polyp immunostained using normal nonspecific
immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original magnification: 4006. The
scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g012
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22637Figure 13. Photomicrographs showing the parietal pleura (A, B) and positive control tonsil (C) immunostained for CXCR3 (A–C).
CXCR3+ cells are stained in red. Photomicrograph D shows negative control slide of tonsil immunostained using normal nonspecific
immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original magnification: 4006.
The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g013
Figure 14. Photomicrographs showing the parietal pleura (A, B) and positive control bronchial biopsy (C) immunostained for CCR5
(A–C). CCR5 positive cells are stained in red. Photomicrograph D shows negative control slide of bronchial biopsy immunostained using normal
nonspecific immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original magnification:
4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g014
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PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e22637Figure 15. Photomicrographs showing the parietal pleura (A, B) and positive control tonsil (C) immunostained for identification of
STAT4+ cells (A–C). STAT4, positive cells are stained brown. Photomicrograph D shows the negative control slide of tonsil immunostained using
normal nonspecific immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original
magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g015
Figure 16. Photomicrographs showing the parietal pleura (A, B) and positive control tonsil (C) immunostained for identification of
T-bet+ cells (A–C). T-bet positive cells are stained brown. Photomicrograph D shows the negative control slide of tonsil immunostained using
normal nonspecific immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original
magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g016
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PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22637Figure 17. Photomicrographs showing the parietal pleura (A, B) and positive control tonsil (C) immunostained for identification of
FOXP3+ cells (A–C). FOXP3 positive cells are stained brown. Photomicrograph D shows the negative control slide of tonsil immunostained using
normal nonspecific immunoglobulins. Results are representative of those from 14 patients with PLTB (A) and 12 patients with NSP (B). Original
magnification: 4006. The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g017
Figure 18. Photomicrographs showing the parietal pleura (A and B) double immunostained for CD4+ cells and CD8+ cells or the
parietal pleural (C and D) double immunostained for Tbet+ cells and GATA-3+ cells. CD4 and Tbet are stained in red and CD8 and GATA-3
are stained in brown. Results are representative of those from 6 patients with PLTB (A and C) and 6 patients with NSP and (B and D). Original
magnification: 10006(A and B) and 4006(C and D). The scale bar represents 50 mm.
doi:10.1371/journal.pone.0022637.g018
Local Immune Response in Tuberculous Pleurisy
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greatest AUC (0.88; 95% confidence interval [CI], 0.7197 to
1.037, p=0.002). Compared to GATA-3 alone, the AUC for the
combination of toluidine blue staining for mast cells, tryptase+
cells and GATA-3+ cells (AUC=0.94; 95% CI 0.8475 to 1.028;
p,0.001) was higher suggesting a better performance with the
combination of the three markers in discriminating between PLTB
and NSP. Despite the greatest AUC obtained for combination of
the three markers compared to GATA-3 alone, the sensitivity and
specificity showed a better performance for GATA-3 alone (cut off
value of the combination 0.1995, sensitivity=100% and specificity
75%; cut off value of GATA-3 alone 13.51, sensitivity=75% and
specificity 100%).
Clinical and biological correlations
There was no significant correlation, between other clinical and
biological data, including age or gender of the patients.
Discussion
This is the first study providing a complete characterization of
the inflammatory cell infiltrate in parietal pleural biopsies obtained
from adult subjects from a non-endemic country, with a low
prevalence of HIV infection, of untreated established PLTB
compared with a control group of NSP.
PLTB patients have significantly increased numbers of CD3+
and CD4+ lymphocytes in their parietal pleura compared with
NSP subjects in accordance with previous human and animal data
[6]. However, a panel of Th1/Th2/Treg/Th17 markers was not
particularly useful for the differential diagnosis of PLTB from
NSP. This may reflect the fact that the T cell-driven inflammation
in the parietal pleura of patients with PLTB is not sufficiently
polarized towards a Th1 pattern and confirms previous data
obtained on the pleural fluid [12]. Marchant and colleagues
reported that most clones derived from tuberculous pleural
effusions from untreated patients show a Th0 cytokine profile
(production of both IFN-c and IL-4), which only polarized towards
a Th1 profile after 6 months of therapy and clinical healing [12].
In animal models of tuberculosis, the transcription factor STAT4,
which is involved in Th1 development, is critical for mounting an
effective Th1 immune response and clearance of M.tuberculosis
from the lungs [17]. The absence of any differences in IFN-c
protein and STAT4 expression and activation in the parietal
pleura in PLTB subjects further suggests the inability of patients to
trigger either a sufficiently strong or early Th1-mediated immune
response.
The presence of a small, but significant, increased number of
CCR4+ cells in our PLTB patients is in keeping with previous data
[13,14] The up-regulation of CCR4 expression in the lungs in an
animal model of tuberculosis [18] suggests the possibility of a Th2
response existing in PLTB. However, the CCR4 molecule is also
expressed by Th subsets distinct from Th2 cells [19] and the
expression of CCR4 on Th2 cells can be driven by GATA-3 in
vitro [20]. These data suggest that CCR4 may be expressed on
other T cell subsets in PLTB. For example most human Th17
clones express CCR4 in vitro [21]. Interestingly, we found an
increased amount of RORC2, a marker of human Th17 cells, in
the parietal pleura of PLTB patients compared to control group.
Animal models suggest that whilst protection against M.tuberculosis
infection does not require IL-17 or IL-23, IL-17 contributes to the
maintenance of the inflammatory response and mycobacteria-
specific Th17 cells may provide long-lasting immunity [22]. Future
studies to better characterize the phenotype and the functional role
of these CCR4+ and Th17 cells in the parietal pleura of patients
with PLTB are warranted.
The absence of an increased number of CXCR3+ cells in the
parietal pleura of subjects with PLTB is in keeping with previous
data obtained in pleural effusions from patients with active PLTB
[23]. The absence of a significant increase of the number of
CCR5+ cells is more surprising and it is in contrast with previous
studies performed in blood [22] and bronchoalveolar lavage (BAL)
[24] of patients with active tuberculosis. However, in an animal
model of tuberculosis, there is differential expression of these
chemokine receptors in T-lymphocytes isolated from different lung
compartments and most cells were both CXCR3+ and CCR5+
[25]. CCR5 is also expressed by both T-lymphocytes and mono-
cytes/macrophages and in vitro CCR5 expression on these cells
may be downregulated in the presence of high levels of its ligands,
such as CCL3, CCL4 and CCL5, which are the major chemokines
produced in response to M.tuberculosis infection in vitro [26].
Activation of FOXP3+ Treg cells may prevent an excessive
inflammatory response to the host and/or may compromise the
elimination of M.tuberculosis. Recent studies suggest an increased
presence of Tregs in PLTB [10,11] with the number of Treg cells
in pleural fluid inversely correlating with local mycobacterial-
specific immunity [27]. We speculate that the absence of
significant differences in the FOXP3+ cell number between PLTB
and NSP subjects, observed in our study, may be a marker of an
excessive downregulation of the immune response against
M.tuberculosis and that this may contribute to its delayed clearance.
We observed a number of toluidine blue+ cells significantly
decreased in PLTB patients compared with NSP subjects.
Toluidine blue stain for mast cells is able to distinguish patients
with PLTB from the control group of subjects with NSP with a
high sensitivity and specificity. Toluidine blue histochemical
staining has a similar overall accuracy to tryptase immunostaining
for mast cells and there was an almost complete overlap of the
counts using these two different techniques. If confirmed, this test
will be particularly useful in less affluent countries where there is
the highest burden of PLTB and where M.tuberculosis culture and
PCR are often unavailable due to their high cost.
In vitro studies and animal models show that activated mast
cells participate to the immune response against M.tuberculosis and
are abundant in human tuberculous lymphadenitis [28–30].
However, our data suggest that the subtype of pleural mast cells
[31] may have a different functional role or are invaded and
destroyed by M.tuberculosis [32].
Table 2. Clinical and demographic characteristics of the
subjects.
PLTB NSP
Number of subjects 14 12
Age (years) 45.164.3 68.862.4*
Gender (M/F) 10/4 10/2
Pleural effusion side (right/left/bilateral) 7/7/0 5/5/2
PPD test (+/2) 8/1 1/2
Presence of fever at admission (yes/no) 12/2 5/7
Ethnic group Caucasian 7
African 2
Asiatic 5
Caucasian 12
Data are presented as means (6SE).
*p,0.01 significantly different from NSP group.
doi:10.1371/journal.pone.0022637.t002
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pleura of PLTB patients. Although the main regulatory pathways
for mast cell differentiation are not well characterized, there is
increasing evidence for a role of GATA-3 in driving mast cell
differentiation of uncommitted but differentiating lymphoid
precursor cells [33]. Interestingly, in-vitro purified protein deriva-
tive (PPD)-stimulated peripheral blood mononuclear cells, ob-
tained from active tuberculosis patients, have reduced GATA-3
mRNA levels [34]. Thus, we may speculate that M.tuberculosis
induces GATA-3 downregulation in the parietal pleural cells
during active PLTB [17]. We have been unable to detect tryptase
and GATA-3 co-localization within the parietal pleural cells in
either PLTB or NSP subjects. For this reason we speculate that the
high number of GATA-3+ cells in the parietal pleura of the
subjects with NSP may represent precursors of mast cells that are
too immature to express tryptase and granules staining for
toluidine blue. This hypothesis is in accord with the data from
similar co-localization studies performed in the bronchial mucosa
of asthmatic patients where the vast majority of GATA-3+
infiltrating immune cells were also CD3+ cells, with a very small
fraction of double positive GATA-3+/tryptase+ cells [35]. Clearly
this area requires further research both in vitro and in vivo.
In conclusion, untreated PLTB in patients from a non-endemic
country with a low prevalence of HIV infection compared with a
control group of subjects with NSP is characterized by the
increased number of CD3, CD4, CCR4 and Th17 cells and by the
presence of a decreased number of mast cells and GATA-3+ cells
in the parietal pleura.
Materials and Methods
Ethics Statement
The study was approved by the ethics committee of the
University-Hospital of Parma, Italy. It has been performed on
archival paraffin-embedded specimens of parietal pleura collected
by medical thoracoscopy between 1996–2006. These procedures
were performed to diagnostic purposes in subjects who were
admitted in the Respiratory Diseases and Thoracic Endoscopy
Unit, Parma Hospital. At the end of diagnostic procedures,
biopsies were archived in the Department of Pathology of Parma
Hospital. The local Ethic-Committee has approved this study and
informed consent has been judged not necessary because of the
impossibility to contact all the patients that underwent the
procedure in the past years. The ethics committee specifically
waived the need for consent also because in this study the
anonymity of the patient is preserved and no genetic studies are
performed.
Subjects
The clinical and microbiological characteristics of subjects
obtained from our patient records are reported in Tables 2 and 3.
The age was significantly higher in NSP patients compared with
Table 4. Summary of the immunohistochemical procedures used to detect the other inflammatory cells.
Antibody
specificity
Company
Manufacturer
Catalogue
code
Source
/host Dilution
Unmasking
procedure
Secondary antibody
and amplification step Chromogen
Positive
control
CD3 DAKO A0452 Rabbit 1:75, solution
of 600 mg/mL
Microwave, 50
mM EDTA, pH 8
Vectastain
Elite kit
DAB Tonsil
CD4 Novocastra
(now Leica
Mycrosystems)
NCL-CD4-1F6 Mouse 1:50 solution
of 50 mg/mL
Microwave, 50
mM EDTA, pH 8
Ultravision
LP kit
DAB Tonsil
CD8 Thermo-
scientific
RM-91160 Rabbit 1:50 solution
of unknown
concentration
Microwave, W-
CAP TEC Buffer
pH 8 Bio-Optica
Vectastain
Elite kit
DAB Tonsil
CD68 DAKO M0876 Mouse 1:100 solution
of 40 mg/mL
Microwave, 10
mM citrate, pH 6
Vectastain
Elite kit
DAB Tonsil
Neutrophil
elastase
DAKO M0752 Mouse 1:50 solution
of 110 mg/mL
Trypsin 0.125%
solution
Vectastain
Elite kit
Fast Red TR/
Naphtol AS-MX
Tonsil
Mast cell
tryptase
DAKO M07052 Mouse 1:50 solution
of 85 mg/mL
Trypsin 0.125%
solution
Ultravision
LP
Fuchsin substrate
chromogen
system
Tonsil
W_CAP TEC=wax capture antigen retrieval solution code 15-6315/F from Bio-Optica (www.bio-optica.it); Ultravision LP Detection System is from Labvision (www.
labvision.com) code Large Volume HRP Polymer (RTU) TL-125-HL; DAB: 3,39-diaminobenzidine tetrahydrochloride.
doi:10.1371/journal.pone.0022637.t004
Table 3. Microbiological characteristics of the subjects (detection of Mycobacterium tuberculosis ).
Sputum Pleural fluid Bronchial washing Pleural biopsy
Number
of
subjects AFB+ Culture+ PCR+ AFB+ Culture+ PCR+ AFB+ Culture+ PCR+ AFB+ Culture+ PCR+
Caseous
necrosis+
PLTB 14 1/6 0/3 0/2 0/10 0/10 5/11 0/3 0/4 0/5 0/11 4/8 7/8 12/14
NSP 12 ND ND ND 0/7 0/7 0/5 0/4 0/1 ND 0/1 ND 0/3 0/12
PLTB: pleural tuberculosis, NSP: nonspecific pleuritis, AFB: acid fast bacilli, PCR: polymerase chain reaction, ND: not determined.
doi:10.1371/journal.pone.0022637.t003
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PLTB and NSP was independently confirmed by three patholo-
gists reviewing microbiological, histological, and molecular biology
characteristics. All samples were obtained from subjects not
treated with anti-tubercular therapy and with an undiagnosed
exudative pleural effusion submitted for medical thoracoscopy at
the Respiratory Diseases and Thoracic Endoscopy Unit, Parma
Hospital, Italy.
Medical thoracoscopy was performed with patient spontane-
ously breathing under local anesthesia in the endoscopy suite
according to a standardized method [36,37].
Pleural fluid was analyzed for pH, biochemical markers, Gram
and Ziehl-Nielsen stains, bacterial and mycobacterial cultures, as
well as for the differential white blood cells count and
cytopathological examination.
Pleural biopsies were used for Ziehl-Nielsen staining and
M.tuberculosis conventional culture in addition to the radiometric
mycobacterial culture system (BACTEC, Becton Dickinson, USA).
PCR for detection of M.tuberculosis in formalin-fixed paraffin/
embedded parietal pleura was performed as previously described
[38].
Pleural biopsies were freshly fixed in 4% buffered formaldehyde
and processed to paraffin wax. Serial sections 6 mm thick were cut
firstly for histochemical analysis and subsequent 4 mm serial
sections were cut for immunohistochemical analysis and were
placed on charged slides as previously reported [39].
Histochemical staining for mast cells and eosinophil
granulocytes in pleura
In order to detect mast cells and eosinophil granulocytes, two
serial sections from each subject included in the study were stained
respectively with toluidine blue [2% toluidine blue in 0.7 M
hydrochloric acid at pH 2.7; Sigma, St. Louis, MO [40]] and
hematoxylin and eosin (H/E).
Immunostaining in pleura for the other inflammatory
cells, Th1, Th2 and Treg markers
Single immunohistochemical staining was performed on serial
sections of parietal pleura biopsies [39]. The primary antibodies
used, their unmasking conditions, the detection kits, the chromo-
gen used and the positive controls are summarized in Tables 4 and
5. After deparaffinization and rehydration to expose the immuno-
reactive epitopes, endogenous peroxidase activity was blocked by
incubating slides in 3% hydrogen peroxide in distilled water
followed by washing in distilled water. Cell membranes were
permeabilized with 0.1% saponin. Non-specific labeling was
blocked by coating with blocking serum for 20 minutes at room
temperature. The sections were incubated for 1 hour at room
temperature with the primary antibody.
For negative control slides, normal non-specific immuno-
globulins (www.scbt.com) of the same animal species as the
primary antibody were used at the same protein concentration.
Positive control slides were included in each staining run for all
the immunostaining performed. After repeated washing steps
with PBS/0.1% saponin, the sections were subsequently
incubated with secondary antibodies for 30 minutes at room
temperature. After further washing steps, the sections were
incubated with amplification reagents for 30 minutes at room
temperature using a specific chromogen. Slides were counter-
stained in hematoxylin and mounted on aqueous or permanent
medium.
Double immunostaining in pleura for CD4/CD8, Tbet/
GATA3 and GATA-3/tryptase
Six sections from PLTB patients and six sections from NSP
subjects were respectively stained for CD4/CD8 or Tbet/GATA3
or GATA-3/tryptase prior to counterstaining with hematoxylin.
The primary antibodies used, their unmasking conditions, the
detection kits, the chromogen used and the positive controls are
summarized in Table 6.
Scoring system for histochemical and
immunohistochemical staining
The presence of staining was determined by a single, blinded,
investigator (LL) by microscopic examination. Stained cells
were quantified in all sections. The image analysis was
performed using an integrated microscope (Olympus, Albert-
s l u n d ,D e n m a r k ) ,v i d e oc a m e r a( J V CD i g i t a lc o l o r ,J V CA / S ,
Tatstrup, Denmark), automated microscope stage (Olympus,
Albertslund, Denmark) and PC running computer Image pro-
Plus Software (Media Cybernetics; www.mediacy.com) to
quantitate the area of staining. Results of the histochemical
staining and of the single immunohistochemical staining are
expressed as positive cells/mm
2 and immunoreactive cells/
mm
2 respectively.
Table 6. Summary of the double staining immunohistochemical procedures.
Antibody
specificity
Company
Manufacturer
Catalogue
code
Source
/host Dilution
Unmasking
procedure
Secondary antibody
and amplification step Chromogen
Positive
control
CD4 Novocastra (now
Leica Mycrosystems)
NCL-CD4-1F6 Mouse 1:50 solution
of 50 mg/mL
Microwave,
10 mM citrate,
pH 6
Vectastain Elite kit Fast Red TR/
Naphtol AS-MX
Tonsil
CD8 Thermo-scientific RB-9009-P Rabbit 1:600 solution
of 200 mg/mL
Microwave,
10 mM citrate,
pH 6
Vectastain Elite kit DAB Tonsil
GATA-3 Santa Cruz sc-22206 Goat 1:50 solution
of 200 mg/mL
Microwave,
10 mM citrate,
pH 6
Vectastain Elite kit DAB Tonsil
T-bet Santa Cruz sc-21749 Mouse 1:800 solution
of 200 mg/mL
Microwave,
10 mM citrate,
pH 6
Vectastain Elite kit Fast Red TR/
Naphtol AS-MX
Tonsil
DAB: 3,39-diaminobenzidine tetrahydrochloride.
doi:10.1371/journal.pone.0022637.t006
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Total RNA was extracted (RNeasy FFPE Kit, Qiagen) from
two 10 mm thick sections of pleural biopsies and 1 mgu s e df o r
cDNA synthesis. cDNA was synthesized using Omniscript RT
kit (Qiagen) as per manufacturer’s instructions. Primer pairs for
human RORC2 (NR1F3, a Th17 marker) (Cat. n.
QT01007685) and IFN-c (Cat. n. QT01007685; a Th1 marker)
were purchased from Qiagen. Quantitative real-time reverse
transcriptase-polymerase chain reaction (RT-PCR) was carried
out using Sybr-green (QuantiFast Sybr Green PCR kit cat. n.
204054, Qiagen) following manufacturer’s protocol as previ-
ously described [41]. At the end of the RT-PCR run a melting
curve analysis was carried out to verify that the cycle threshold
(Ct) values were based upon a single PCR product (data not
shown). Relative levels of cDNAs were established using the
DDCt methods against the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (Cat. n.Hs_GAPDH_2
_SG QuantiTect Primer Assay, Qiagen). After normalization,
the value of DCt was subtracted from 45 (total number of RT-
PCR cycles), thus higher DCt levels indicate higher mRNA
levels.
Statistical Analysis
Results are expressed as means 6 SE. Comparisons between the
two groups were performed with the nonparametric Mann–
Whitney U test. Correlation coefficients were calculated with
Spearman’s rank method. In addition, receiver operator charac-
teristic (ROC) analysis was performed and the area under the
curve (AUC) was calculated separately for toluidine blue staining
for detection of mast cells, tryptase+ cells and GATA-3+ cells to
discriminate between NSP and PLTB subjects. Logistic regression
(with ROC curve) was then used to identify the combination of the
three markers. Overall accuracy was assessed with the use of a
ROC curve, which plots the true positive rate (sensitivity) against
the false positive rate (1-specificity). A P value of less than 0.05 was
considered to indicate statistical significance. All reported P values
are two-sided. Data analysis was performed using Prism 4 for
Macintosh (v 4.0b, GraphPad Prism software inc., San Diego,
California, USA).
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